国家低价药品价格改革对低价药品生产企业的影响研究  

Studying on the influence of national cheap-drug price reform on manufacturers

作　　者：朱玄[1] 李树祥[1] 褚淑贞[1] 

机构地区：[1]中国药科大学国际医药商学院,江苏南京211198

出　　处：《中国卫生事业管理》2015年第10期761-764,共4页Chinese Health Service Management

基　　金：广东医药价格协会2014年课题"低价药品价格改革对医药行业的影响研究"

摘　　要：2014年国家发改委出台了三份低价药品价格改革的政策文件,拉开了新一轮药品价格调控的主动性变革。此次变革将涉及众多利益相关者,尤其对于低价药品生产企业具有重大影响。文章针对广东和江苏两个省份的生产企业进行问卷调研,通过描述性统计分析与因子分析方法来探讨低价药品价格改革政策对低价药品生产企业的影响,并总结提出政策性意见。Three policy papers of cheap-drug price reform were issued by the National Development and Reform Commission in 2014,which launched a new round of reform on regulating drug prices. Many stakeholders were involved in, especially the manu- facturers of cheap-drugs. Some pharmaceutical production enterprises in Guangdong and Jiangsu Province were surveyed with ques- tionnaires. Based on which, the influence of national cheap-drug price reform on manufacturers was analyzed with descriptive analy- sis and factor analysis. And some PolicY suggestions were nut forward.

关 键 词：低价药品 低价药品生产企业 价格改革 

分 类 号：R95[医药卫生—药学]